Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Anti-Cancer Agents in Medicinal Chemistry|July 24, 2020
The Use of Bio-Active Compounds of Citrus Fruits as Chemopreventive Agents and Inhibitor of Cancer Cells ViabilityMahboubeh Tajaldini, Jahanbakhsh Asadi
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|August 4, 2026
Investigation of the effect of intrauterine injection of platelet-rich plasma (PRP) on the results of in vitro fertilization (IVF): A cohort studyFarahnazsadat Ahmadi, Fatemeh Nakhaei, Mahboubeh Tajaldini
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 11, 2019
Protective and anticancer effects of orange peel extract and naringin in doxorubicin treated esophageal cancer stem cell xenograft tumor mouse modelMahboubeh Tajaldini, Firooz Samadi, Ayyoob Khosravi, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 12, 2020
Selective Inhibition of Esophageal Cancer Stem-like Cells with SalinomycinMahdi Zarei, Marie S Jazi, Mahboubeh Tajaldini, et al.
Journal of Reproductive Immunology|October 1, 2025
The impact of platelet-rich plasma (PRP) on ovarian function and oocyte quality: A comprehensive reviewFarahnazsadat Ahmadi, Roghaye Gharaei, Elham Shirali, et al.
Cancer Medicine|February 13, 2024
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactionsHossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, et al.
BMC Oral Health|July 27, 2024
Assessment of a combined mouthwash on pain relief in pericoronitis: a randomized clinical studyNeman Arekhi, Nazanin Mortazavi, Emad Bahramnejad, et al.
Gene|May 8, 2025
A Bioligical Perspective on the role of miR-206 in Colorectal cancerMahsa Akbari Oryani, Aseel Kamil Mohammad Al-Mosawi, Hossein Javid, et al.
Nanotechnology|May 18, 2026
Synergistic Engineering of pH-Responsive MSN@ZIF-8 Core-Shell Nanohybrids for Targeted Cancer Therapy: From Rational Design to Clinical PotentialMojtaba Tarin, Mahsa Akbari Oryani, Dr Hossein Javid, et al.
Immunotherapy|July 13, 2026
Modified Dendritic cells as a therapeutic platform in hematologic malignancies with translational insights from central nervous system tumorsMahsa Akbari Oryani, Hossein Tabarsa, Ghazaleh Hatamian, et al.
Pageof 2